215 related articles for article (PubMed ID: 23857307)
1. Feline foamy virus-based vectors: advantages of an authentic animal model.
Liu W; Lei J; Liu Y; Lukic DS; Räthe AM; Bao Q; Kehl T; Bleiholder A; Hechler T; Löchelt M
Viruses; 2013 Jul; 5(7):1702-18. PubMed ID: 23857307
[TBL] [Abstract][Full Text] [Related]
2. Application of chimeric feline foamy virus-based retroviral vectors for the induction of antiviral immunity in cats.
Schwantes A; Truyen U; Weikel J; Weiss C; Löchelt M
J Virol; 2003 Jul; 77(14):7830-42. PubMed ID: 12829823
[TBL] [Abstract][Full Text] [Related]
3. Replacement of feline foamy virus bet by feline immunodeficiency virus vif yields replicative virus with novel vaccine candidate potential.
Ledesma-Feliciano C; Hagen S; Troyer R; Zheng X; Musselman E; Slavkovic Lukic D; Franke AM; Maeda D; Zielonka J; Münk C; Wei G; VandeWoude S; Löchelt M
Retrovirology; 2018 May; 15(1):38. PubMed ID: 29769087
[TBL] [Abstract][Full Text] [Related]
4. Importance of the major splice donor and redefinition of cis-acting sequences of gutless feline foamy virus vectors.
Liu W; Backes P; Löchelt M
Virology; 2009 Nov; 394(2):208-17. PubMed ID: 19775717
[TBL] [Abstract][Full Text] [Related]
5. Construction and functional characterization of feline foamy virus-based retroviral vectors.
Schwantes A; Ortlepp I; Löchelt M
Virology; 2002 Sep; 301(1):53-63. PubMed ID: 12359446
[TBL] [Abstract][Full Text] [Related]
6. Construction and characterization of efficient, stable and safe replication-deficient foamy virus vectors.
Bastone P; Romen F; Liu W; Wirtz R; Koch U; Josephson N; Langbein S; Löchelt M
Gene Ther; 2007 Apr; 14(7):613-20. PubMed ID: 17203107
[TBL] [Abstract][Full Text] [Related]
7. Feline foamy virus-mediated marker gene transfer: identification of essential genetic elements and influence of truncated and chimeric proteins.
Bastone P; Bravo IG; Löchelt M
Virology; 2006 Apr; 348(1):190-9. PubMed ID: 16443252
[TBL] [Abstract][Full Text] [Related]
8. Feline foamy virus genome and replication strategy.
Roy J; Rudolph W; Juretzek T; Gärtner K; Bock M; Herchenröder O; Lindemann D; Heinkelein M; Rethwilm A
J Virol; 2003 Nov; 77(21):11324-31. PubMed ID: 14557618
[TBL] [Abstract][Full Text] [Related]
9. Isolation and sequencing of infectious clones of feline foamy virus and a human/feline foamy virus Env chimera.
Hatama S; Otake K; Omoto S; Murase Y; Ikemoto A; Mochizuki M; Takahashi E; Okuyama H; Fujii Y
J Gen Virol; 2001 Dec; 82(Pt 12):2999-3004. PubMed ID: 11714976
[TBL] [Abstract][Full Text] [Related]
10. First report on the prevalence and genetic relatedness of Feline Foamy Virus (FFV) from Turkish domestic cats.
Koç BT; Oğuzoğlu TÇ
Virus Res; 2019 Dec; 274():197768. PubMed ID: 31562905
[TBL] [Abstract][Full Text] [Related]
11. Kinetics and characteristics of replication-competent revertants derived from self-inactivating foamy virus vectors.
Bastone P; Löchelt M
Gene Ther; 2004 Mar; 11(5):465-73. PubMed ID: 14973540
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Molecular Features of Feline Foamy Virus and Feline Leukemia Virus Co-Infection in Naturally-Infected Cats.
Cavalcante LTF; Muniz CP; Jia H; Augusto AM; Troccoli F; Medeiros SO; Dias CGA; Switzer WM; Soares MA; Santos AF
Viruses; 2018 Dec; 10(12):. PubMed ID: 30544924
[TBL] [Abstract][Full Text] [Related]
13. Feline Foamy Virus Infection: Characterization of Experimental Infection and Prevalence of Natural Infection in Domestic Cats with and without Chronic Kidney Disease.
Ledesma-Feliciano C; Troyer RM; Zheng X; Miller C; Cianciolo R; Bordicchia M; Dannemiller N; Gagne R; Beatty J; Quimby J; Löchelt M; VandeWoude S
Viruses; 2019 Jul; 11(7):. PubMed ID: 31330990
[TBL] [Abstract][Full Text] [Related]
14. Foamy virus vectors.
Mergia A; Heinkelein M
Curr Top Microbiol Immunol; 2003; 277():131-59. PubMed ID: 12908771
[TBL] [Abstract][Full Text] [Related]
15. Is feline foamy virus really apathogenic?
German AC; Harbour DA; Helps CR; Gruffydd-Jones TJ
Vet Immunol Immunopathol; 2008 May; 123(1-2):114-8. PubMed ID: 18342375
[TBL] [Abstract][Full Text] [Related]
16. The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein.
Löchelt M; Romen F; Bastone P; Muckenfuss H; Kirchner N; Kim YB; Truyen U; Rösler U; Battenberg M; Saib A; Flory E; Cichutek K; Münk C
Proc Natl Acad Sci U S A; 2005 May; 102(22):7982-7. PubMed ID: 15911774
[TBL] [Abstract][Full Text] [Related]
17. Replication-Competent Foamy Virus Vaccine Vectors as Novel Epitope Scaffolds for Immunotherapy.
Lei J; Osen W; Gardyan A; Hotz-Wagenblatt A; Wei G; Gissmann L; Eichmüller S; Löchelt M
PLoS One; 2015; 10(9):e0138458. PubMed ID: 26397953
[TBL] [Abstract][Full Text] [Related]
18. Mutagenesis of N-terminal residues of feline foamy virus Gag reveals entirely distinct functions during capsid formation, particle assembly, Gag processing and budding.
Liu Y; Betts MJ; Lei J; Wei G; Bao Q; Kehl T; Russell RB; Löchelt M
Retrovirology; 2016 Aug; 13(1):57. PubMed ID: 27549192
[TBL] [Abstract][Full Text] [Related]
19. Foamy virus vectors for gene transfer.
Trobridge GD
Expert Opin Biol Ther; 2009 Nov; 9(11):1427-36. PubMed ID: 19743892
[TBL] [Abstract][Full Text] [Related]
20. Foamy virus vectors: an awaited alternative to gammaretro- and lentiviral vectors.
Rethwilm A
Curr Gene Ther; 2007 Aug; 7(4):261-71. PubMed ID: 17969559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
